NFE2L2 and non-small cell lung carcinoma: A perfect example of new ferroptosis-based therapeutic strategy in NSCLC is the overcoming of cisplatin resistance within NF-E2 related factor 2 (Nrf2)/light chain of System xc−(xCT) pathway given by Yu Li et al. [20].